Newcleo
PublicNewcleo is now publicly traded
The data on this page reflects Newcleo's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Feb 4, 2026
Total Funding Raised
$670M
Company Overview
Newcleo is a nuclear energy company that develops Generation IV small modular lead-cooled fast reactors (LFRs) fueled by reprocessed nuclear waste.
Sector
Energy
Verticals
Advanced Manufacturing, CleanTech, Climate Tech, Industrials, Infrastructure, Manufacturing
AI Layer
Non-AI
Keywords
Newcleo Comparables
Compare Newcleo with similar companies based on industry and business-model similarity.
Newcleo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 4, 2026 | ||||
| Series A | Sep 30, 2024 | ||||
| VC Round | Jun 20, 2022 | ||||
| Seed | Aug 31, 2021 |
Key People
Founding team and executive leadership
Newcleo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inarcassa | Series A |
| UK government | VC Round |
| Eni | VC Round |
| Azimut | Seed |
| Indaco Venture Partners SGR | Series A |
| Maire | Series A |
| Alchimia Investments | VC Round |
Recent news
Latest coverage and updates
- receives_financingSep 21, 2026
Newcleo Ltd receives $247M in gross proceeds on Sep 21st '26
- receives_financingAug 27, 2026
Newcleo Ltd received financing of $1.17M in French public funding on Aug 27th '26.
- partners_withAug 27, 2026
Newcleo Ltd partnered with Abmi on Aug 27th '26.
- expands_facilitiesAug 7, 2026
Newcleo Ltd expands facilities to United States, Northern America, Americas.
- expands_facilitiesAug 4, 2026
Newcleo Ltd expands facilities to Chusclan, 30200, France, Western Europe, Europe.
Newcleo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access